VVOS – vivos therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Vivos Therapeutics (NASDAQ:VVOS) had its price target lowered by analysts at Ascendiant Capital Markets from $6.50 to $5.50. They now have a "buy" rating on the stock.
Vivos Therapeutics (NASDAQ:VVOS) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Vivos Therapeutics Inc (VVOS) Q3 2025 Earnings Call Highlights: Revenue Surge Amid Strategic ... [Yahoo! Finance]
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 [Yahoo! Finance]
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
Form 8-K Vivos Therapeutics, Inc. For: Nov 19
Form 10-Q Vivos Therapeutics, Inc. For: Sep 30
Form NT 10-Q Vivos Therapeutics, Inc. For: Sep 30
Form 8-K Vivos Therapeutics, Inc. For: Nov 04
Form 424B5 Vivos Therapeutics, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.